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Abstract 
Background: Conventional risk factors contribute to the pathogenesis of ischaemic stroke and 
differences in the pattern of these may explain the heterogeneity of disease presentation in different 
populations.  In Chinese, middle cerebral artery (MCA) stenosis is the most commonly identified 
intracranial vascular lesion. 
Objectives: To identify determinants associated with increasing severity of MCA stenosis in 
asymptomatic Chinese Type 2 diabetic patients with and without MCA stenosis determined using 
transcranial Doppler. 
Methods:  Anthropometric and fasting biochemical parameters were compared between Type 2 
diabetic patients with MCA stenosis in 1 (n=185) or both (n=200) vessels and 1492 without 
evidence of stenosis.   
Results: Increasing MCA stenotic vascular involvement was associated with significantly 
increasing age, duration of diabetes, systolic blood pressure, and LDL-cholesterol, but with lower 
glucose levels.  There was also increased prevalence of hypertension, dyslipidaemia and use of 
blood pressure and glucose-lowering agents in the patients with MCA stenosis.  Concomitant 
significant increases in prevalence of peripheral vascular disease and retinopathy were also 
observed in the patients with MCA stenosis. 
Conclusions: In these asymptomatic Type 2 diabetics a number of cardiovascular risk factors were 
closely associated with MCA stenosis.   
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Introduction 
Stroke is a major cause of mortality and morbidity in Oriental populations, with the World 
Health Organisation estimating 1.6 million stroke-related deaths in China alone in 2000, and rates 
are predicted to increase as the population ages (1).  In China in 1999, mortality resulting from 
stroke (137.7/100,000) was second only to that due to malignancy (2).  Improved control of risk 
factors has led to a reduction in age-adjusted stroke mortality rates, but as the population ages, 
absolute rates are rising. 
In Oriental populations, apart from Singapore, higher mortality is attributed to stroke than in 
Caucasian populations where coronary heart disease generally predominates (3,4).  However, even 
within China there is a great variability in stroke rates, which are generally higher in urban than in 
rural populations and in the North relative to the South.  For instance in 1986 the annual age-
standardised incidence of stroke was 234.4 in Jilin Province in the north-east vs. 53.2 per 100,000 
population in Guangdong in southern China (5). The north-south differences were in part due to the 
increased prevalence of hypertension in the North with a 10% increase in prevalence of 
hypertension being associated with a 2.7-fold higher incidence of stroke (5).  These studies support 
the importance of environmental and lifestyle factors in the aetiology of stroke.  
Stroke is a heterogeneous disorder with marked ethnic differences in the distribution of 
arterial lesions.  Intracerebral haemorrhage has been reported to be 2-3 times more frequent in 
Chinese than in Caucasian populations, accounting for 20-30% of strokes (6).  In 114 non-selected 
autopsy subjects from Hong Kong intracranial was found to be most severe than extracranial 
stenosis (7). In Hong Kong, of 705 consecutively recruited stroke patients, occlusive arteries were 
found in 345 patients (49%), 37% of the total had only intracranial stenosis, 10% tandem lesions 
and 2.3% only extracranial lesions (8).  In Caucasian patients referred for the evaluation of 
asymptomatic carotid bruits, 39.2% were found to have extracranial carotid stenosis, and only 
12.9% were found to have intracranial stenosis (9).  In Chinese stenosis of the middle cerebral 
artery (MCA) was the most common lesion, found in 35.9% of the patients (8).  The 
cerebrovascular lesions tended to be more diffuse rather than discrete as generally observed in 
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Caucasian populations with over half having two or more (up to nine) lesions.  In a population-
based study of 590 rural Chinese subjects screened by transcranial Doppler, 7% over 40 years were 
found to have intracranial stenosis (2).  We have previously shown that the presence and extent of 
vascular lesions independently predicted the risk of stroke or death at 6 months (8).  Hypertension, 
diabetes and a family history of stroke and a history of heart disease were independent predictors of 
intracranial stenosis with risk increasing substantially with increasing coexisting factors (2).  In a 
clinic-based study of more than 3000 asymptomatic Chinese individuals similar risk factors were 
identified.  Furthermore, the prevalence of intracranial stenosis was up to 25% in those subjects 
with multiple risk factors (2).  In Chinese patients with acute stroke screened for diabetes or 
impaired glucose tolerance over half were found to have these conditions, many of whom were 
undiagnosed, with nearly all having ischaemic stroke (10).  Interventions that target the modifiable 
risk factors, such as diabetes and hypertension have been shown to reduce the development of 
stroke in Chinese subjects (11). 
In this study in Type 2 diabetic Chinese subjects asymptomatic for cerebrovascular disease 
we determined the factors contributing to MCA stenotic vascular involvement, the most common 
form of cerebrovascular ischaemia in this population.   
 
Methods  
The study protocol was approved by the Clinical Research Ethics Committee of the Chinese 
University of Hong Kong.  All 2165 Type 2 diabetic patients, recruited from the diabetes and 
neurology clinics at the Prince of Wales Hospital, were unrelated and gave written, informed 
consent.  They were of Han Chinese origin, without any known ancestors of other ethnic origin, and 
were living in the Hong Kong Special Administrative Region of China at the time of the study.  
Patients were considered diabetic if the fasting plasma glucose was ≥7.8 mmol/L or the two hour 
post 75g oral glucose tolerance test plasma glucose level was ≥11.1 mmol/L (12)  Type 1 diabetic 
patients (1.7% from an initial 2202 patients recruited) were defined on the basis of acute symptoms 
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with heavy ketonuria (>3+) or ketoacidosis at diagnosis or requirement for continuous insulin 
treatment within one year of diagnosis, and were excluded from the study (12)  None of the type 2 
diabetic patients screened had previously suffered from a stroke. 
The patients were examined by transcranial Doppler (EME TC-2000).  A single experienced 
operator (RL) performed all the transcranial Doppler evaluations (Figure).  We studied the middle 
cerebral artery (MCA) using a standardised protocol examining the artery with 4cm increments 
through the temporal window at 52-64 mm. The criteria for occlusive arteries were defined by an 
abnormally high peak systolic flow velocity of ≥140 cm/s for the MCA (8).  Apart from the above 
velocity criteria, we took into account the age of patients, presence of turbulence or musical sound, 
and whether the abnormal velocity was segmental.  Where it was not possible for insonation of the 
cerebral arteries through the temporal window, the patients (13.3% of the total group) were 
excluded from the analyses.  The subjects who were excluded were slightly older (59.8±10.4 vs 
54.9±11.3 years), with slightly higher systolic blood pressure (142±22 vs 138±22 mm Hg) and with 
a lower proportion of males (28.7 vs 40.8%, all p<0.05) than those included in the study, but 
otherwise the remaining conventional cardiovascular risk factors did not differ significantly 
between the groups.  The above diagnostic criteria in our neurovascular laboratory were based on 
our laboratory references, which had a quality assurance program with supplementary angiographic 
studies.  At our laboratory, we perform >1200 transcranial Doppler examinations each year and had 
validated our criteria with magnetic resonance angiography (13) and clinical outcome (8). 
Measurement of seated blood pressure, anthropometric (waist circumference and body mass 
index) and plasma biochemical (lipid and glycaemic profiles) parameters taken after an overnight 
fast were performed as described in detail previously (14).  The patients’ medications were 
suspended for the morning of the examination providing assessment of trough levels, therefore 
assessment of the haemodynamic parameters as continuous variables is not appropriate as some 
patients were on hypertension treatment.  Subjects were defined as hypertensive, if, after 5 minutes 
rest, their seated systolic blood pressure (SBP) was ≥140 mm Hg and/or diastolic blood pressure 
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(DBP) ≥90 mm Hg on at least two occasions or they were receiving blood pressure-lowering 
medication.  Patients were assessed to rule out secondary causes of hypertension and renal disease. 
Retinopathy was assessed by an ophthalmologist in all the patients.  The fundi were 
examined through dilated pupils and retinopathy was considered to be present if there was one or 
more areas of haemorrhages, microaneurysms, cotton wool spots and/or laser coagulation scars 
related to diabetic retinopathy.  Symptomatic peripheral vascular disease was diagnosed if 
claudication, gangrene or ischaemia-related amputation were present.  Foot pulses were examined 
in each patient and the ankle-brachial systolic arterial pressure ratio (ABR) was determined by 
Doppler examination in those with abnormal pulses.  An ABR <0.9 in either leg was considered 
suggestive and <0.7 confirmatory of PVD (15).  Histories of coronary and cerebrovascular disease 
were recorded, and patients with the latter were excluded. 
Data from normally distributed parameters are presented as mean±SD, whereas skewed data 
were logarithmically transformed and expressed as geometric mean with 95% confidence intervals. 
Differences in anthropometric and fasting plasma biochemical parameters between those patients 
with or without MCA stenosis were examined using the analysis of variance.  A Bonferroni post 
hoc test was used to determine differences between the individual groups.  Dichotomous variables 
were compared using the χ2-test.  Gender was coded 0 and 1 for male and female, respectively.  
Those patients with and without MCA stenoses were coded 0 and 1, respectively.  Those variables 
that correlated with the MCA stenosis were included in the forward conditional linear regression 
analyses to determine independent predictors of this condition.  These variables included age, 
gender, systolic blood pressure, diagnosis of hypertension, glucose, diagnosis of dyslipidaemia and 
LDL-cholesterol levels and duration of diabetes.  The variables included in the analyses were 
linearly related to the dependent variable. The Statistical Package for the Social Sciences was used 
in the analyses (SPSS. version 11.0.1, 2001, SPSS Inc, Chicago, Illinois, USA). 
 
Results 
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Of the 2165 Type 2 diabetic patients with asymptomatic cerebrovascular involvement the presence 
or absence of stenosis in the MCA could be determined in 1877 patients, in whom evidence of 
MCA stenosis was identified in 385 subjects (20.6%).  This included 185 (48.1%) with single 
vessel involvement and the remainder with stenoses in both vessels.   
The demographic characteristics and prevalence rates of concomitant disorders of the Type 
2 diabetic Chinese patients with or without evidence of middle cerebral artery stenosis are 
described in Table 1.  Age and age of onset of diabetes and duration were significantly higher in 
those patients with an increasing number of stenotic vessels.  Systolic blood pressure, prevalence 
and treatment of hypertension and total and LDL-cholesterol and prevalence of dyslipidaemia were 
also significantly increased. Glycosylated haemoglobin A1c did not significantly differ between the 
three groups, but glucose surprisingly decreased with increasing vascular involvement.  However, 
in contrast the proportion of the patients receiving glucose-lowering therapy increased. A number of 
other concomitant vascular disorders were also associated with the MCA stenoses, including 
peripheral vascular disease and retinopathy (Table 1). 
Using stepwise multiple regression the presence of hypertension (β=0.11, p=0.003), age 
(β=0.07, p=0.013), LDL-cholesterol (β=0.08, p=0.003), glucose (β=0.07, p=0.006), and systolic 
blood pressure (β=0.09, p=0.021) were independent predictors of the presence of the MCA in one 
or both vessels (MCA stenosis = [0.15⋅hypertension] + [0.004⋅age] + [0.06⋅LDL-cholesterol] – 
[0.32⋅glucose] + [0.03⋅systolic blood pressure]-0.28; R2=0.067, F=18.2, p<0.001). 
 
Discussion 
In Chinese subjects, MCA stenosis is the most commonly identified intracranial arterial lesion (8), 
and in the current study we investigated Type 2 diabetics, who are particularly prone to vascular 
disease (16).  A total of 20.6% of the Type 2 diabetic subjects were found to have evidence of MCA 
stenosis in one or both vessels, with the high rate being due to enrichment of the sample with 
diabetic patients recruited from the general medical and diabetic clinics.  
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The level of a number of factors were increased with increasing presence of the MCA 
stenosis, including age, female gender, age at diabetic onset and duration, systolic blood pressure 
and the presence of hypertension, and LDL-cholesterol, whereas glycaemia decreased, although the 
prevalence of glucose-lowering treatment increased.  Although the age at onset of diabetes 
increased by 2.7 years this difference is unlikely to be clinically significant. 
In the current study, despite a significant decrease in the proportion of male subjects with 
the number of stenotic MCA, gender was not an independent risk factor after the other conventional 
risk factors were considered.  Although men have a higher incidence of stroke, the longer life 
expectancy of females results in a greater proportion of females having strokes (4).  This may also 
result from more men dying at younger ages from heart disease, although there was no evidence of 
survivor bias in the current study, selection bias in the older patients may have occurred. 
Age further contributes to the development of hypertension and stroke (4,17), and was an 
independent predictor of the number of affected vessels in the current study. Age acts as a 
composite factor associated with a clustering of a number of risk factors.  Regression equations 
function to explain the largest proportion of the variance in the model, rather than identifying 
biologically relevant parameters involved in the disease pathogenesis.  As such composite variables 
are most likely to be strong independent predictors of the variable of interest. It is also important to 
remember that exclusion of a parameter does not exclude it from directly contributing to the 
pathogenesis of the disorder, merely the variance attributed to the parameter is accounted for by 
other variables. 
Type 2 diabetes is closely associated with micro- and macrovascular disease, the major 
causes of morbidity and mortality in these patients (16), as can be seen by the high prevalence of 
MCA stenoses in these diabetic subjects.  Interventions that lower glycaemia particularly, such as 
from the UK Prospective Diabetes Study reduced microvascular disease, but not macrovascular 
disease (18).  This finding fits the data from the current study of diabetic patients, however it is not 
certain why the increasing vascular involvement was associated with slightly, but significantly 
lower glucose levels.  There was an increasing proportion of these patients who were receiving 
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glucose-lowering therapy that may have contributed to lower glucose levels through better 
glycaemic control.   
It has been suggested that lipid parameters are more closely associated with extracranial and 
coronary atherosclerosis, and blood pressure with intracranial atherosclerosis (19).  However, in the 
Oslo study LDL-cholesterol was an independent predictor of the development of intracranial 
atherogenesis, as was seen in the current study.  Lipid-lowering studies have clearly confirmed the 
importance of cholesterol in the pathogenesis of ischaemic stroke.  In the Heart Protection Study 
treatment with simvastatin lowered the risk of ischaemic stroke by 30% compared to placebo (20), 
and similar observations in the Eastern Stroke and Coronary Heart Disease Study supports such 
findings (17). 
Blood pressure is a major predictor of haemorrhagic and atherogenic forms of stroke (4,17).  
Hypertension has been reported to be associated with more severe intercranial atherosclerosis, but 
not in extracranial cerebral vessels, and this is supported by a number of studies (21,22).  In the 
current study, both systolic blood pressure, despite the confounding by treatment, and the 
proportion of subjects with hypertension were significantly elevated in subjects with MCA stenosis 
and were independent predictors for the increasing MCA stenotic vascular involvement. The 
inclusion of both blood pressure-related parameters suggests each contributed additional 
information in the regression analyses. Hypertension has also been reported as an independent 
predictor of stroke in other Chinese populations (5). The UK Prospective Diabetes Study 
highlighted the clear benefits of lowering blood pressure to reduce vascular disease in type 2 
diabetic patients (23). Although the relationship between the MCA stenoses and systolic blood 
pressure was significant, it is likely blood pressure-lowering treatment will have attenuated it.  
Therefore, the dichotomous classification of hypertension that combines blood pressure levels and 
treatment status, but which is generally less informative than a continuously distributed parameter, 
attributes an additional proportion of the variance to blood pressure. Treatment effects on diastolic 
blood pressure may have similarly limited any relationship, which contrasts with the Oslo study 
where, despite patients receiving blood pressure-lowering treatment, it has been reported to more 
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strongly predict fatal stroke than systolic blood pressure (24). As diastolic blood pressure levels 
were similar between the groups, yet systolic blood pressure increased, pulse pressure also 
increased and may contribute to the development of cerebrovascular disease in these patients. 
In Chinese patients who had experienced acute cerebral ischaemia, the presence of occluded 
vessels was the strongest predictor of further vascular events or death within 6 months (8).  The 
majority of the subsequent events were strokes rather than from ischaemic heart disease as has been 
reported in other ischaemic stroke series (8,25).  The current data show the close relationship 
between modifiable cardiovascular risk factors and middle artery stenoses and, by extrapolation, the 
increased risk of cardiovascular events and highlight the need for coordinated treatment of risk 
factors to minimise such events. 
 In summary, a number of conventional cardiovascular risk factors including age, LDL-
cholesterol and in particular systolic blood pressure or hypertensive status contributed to increasing 
MCA stenotic vascular involvement in this group of Type 2 diabetic patients.  
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Table 1 Demographic features and prevalence rates of concomitant disorders in the 1877 
Chinese Type 2 diabetic patients with and without evidence of middle cerebral artery (MCA) 
stenosis  
Parameters (%) Middle cerebral artery stenosis  
 None One vessel Two vessel p value 
Numbers 1492 185 200 - 
Age (years) 54.0±11.4 58.3±10.5* 58.8±10.3* <0.001 
Gender (% Male) 42.2 36.2 35.5 0.031 
Duration of diabetes (years) 4.1 (3.8-4.3) 4.6 (3.7-5.8) 5.4 (4.4-6.6)* 0.030 
Age of diabetes onset (years) 47.8±11.2 49.6±10.0 50.5±10.8* 0.010 
Body mass index (kg/m2) 24.8±3.7 24.3±3.6 24.4±3.4 NS 
Waist circumference (cm) 84.2±9.6 84.7±10.6 85.2±8.2 NS 
Systolic blood pressure (mm Hg) 136±21 143±22* 149±24*† <0.001 
Diastolic blood pressure (mm Hg) 80±16 80±12 80±15 NS 
Mean arterial pressure (mm Hg) 99±15 101±13 103±14* 0.001 
Pulse pressure (mm Hg) 55±20 63±18* 69±20*† <0.001 
Glucose (mmol/L) 8.66 (8.49-8.84) 8.45 (8.02-8.91) 8.06 (7.67-8.48)* 0.039 
Glycosylated haemoglobin A1c(%) 7.8±2.0 7.8±1.7 7.6±1.6 NS 
Total cholesterol (mmol/L) 5.6±1.1 5.7±1.0 5.8±0.9* 0.012 
HDL-cholesterol (mmol/L) 1.26±0.32 1.27±0.32 1.26±0.35 NS 
LDL-cholesterol (mmol/L) 3.6±0.9 3.8±0.9* 3.8±0.8* <0.001 
Triglyceride (mmol/L) 1.43 (1.28-1.48) 1.39 (1.28-1.51) 1.44 (1.34-1.56) NS 
Drug treatment of diabetes (%) 78.3 84.3 86.4 0.033 
Prevalence of hypertension (Rx) (%) 50.6 (29.8) 71.7* (51.7)* 79.0* (51.9)* <0.001 
Prevalence of dyslipidaemia (Rx) (%) 48.0 (4.5) 54.1 (4.8) 56.4* (3.6) 0.021 (NS)
Peripheral vascular disease (%) 3.4 4.2 9.5* 0.006 
History of myocardial infarction (%) 3.1 5.3 4.2 NS 
Retinopathy (%) 24.1 27.8 39.6* 0.001 
Smoking consumption (ex/current, %) 13.5 / 13.4 11.9 / 12.6 13.8 / 12.0 NS 
Alcohol consumption (ex/current, %) 11.7 / 7.2 12.6 / 8.4 13.7 / 7.4 NS 
Mean±SD or geometric mean (95% confidence intervals); NS = non-significant, Rx=receiving 
therapy, p value is for analysis of variance between all three groups, *p<0.05 compared to the no 
stenosis group, †p<0.05 compared to the single vessel group  
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Figure: An example of middle cerebral artery stenosis detected by transcranial Doppler 
ultrasound with a peak systolic velocity up to 220 cm/sec and turbulent flow. The stenosis was 
confirmed by a magnetic resonance angiography. 
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